• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

藻酸盐与透明质酸作为髓核细胞载体的比较:椎间盘退变再生结果的研究

Alginate vs. Hyaluronic Acid as Carriers for Nucleus Pulposus Cells: A Study on Regenerative Outcomes in Disc Degeneration.

作者信息

Ogasawara Shota, Schol Jordy, Sakai Daisuke, Warita Takayuki, Susumu Takano, Nakamura Yoshihiko, Sako Kosuke, Tamagawa Shota, Matsushita Erika, Soma Hazuki, Sato Masato, Watanabe Masahiko

机构信息

Department of Orthopedic Surgery, Tokai University School of Medicine, 143 Shimokasuya, Isehara 259-1193, Japan.

Center for Musculoskeletal Innovative Research and Advancement (C-MiRA), Tokai University Graduate School, 143 Shimokasuya, Isehara 259-1193, Japan.

出版信息

Cells. 2024 Nov 30;13(23):1984. doi: 10.3390/cells13231984.

DOI:10.3390/cells13231984
PMID:39682732
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11639827/
Abstract

Intervertebral disc degeneration is a leading cause of chronic low back pain, affecting millions globally. Regenerative medicine, particularly cell-based therapies, presents a promising therapeutic strategy. This study evaluates the comparative efficacy of two biomaterials-hyaluronic acid (HA) and alginate-as carriers for nucleus pulposus (NP) cell transplantation in a beagle model of induced disc degeneration. NP cells were isolated, cultured, and injected with either HA or alginate into degenerated discs, with saline and non-cell-loaded carriers used as controls. Disc height index, T2-weighted MRI, and histological analyses were conducted over a 12-week follow-up period to assess reparative outcomes. Imaging revealed that both carrier and cell-loaded treatments improved outcomes compared to degenerative controls, with cell-loaded carriers consistently outperforming carrier-only treated discs. Histological assessments supported these findings, showing trends toward extracellular matrix restoration in both treatment groups. While both biomaterials demonstrated reparative potential, HA showed greater consistency in supporting NP cells in promoting disc regeneration. These results underscore HA's potential as a superior carrier for NP cell-based therapies in addressing disc degeneration.

摘要

椎间盘退变是慢性下腰痛的主要原因,全球数百万人受其影响。再生医学,尤其是基于细胞的疗法,是一种很有前景的治疗策略。本研究在诱导椎间盘退变的比格犬模型中,评估了两种生物材料——透明质酸(HA)和藻酸盐——作为髓核(NP)细胞移植载体的相对疗效。分离、培养NP细胞,然后将其与HA或藻酸盐一起注射到退变椎间盘中,以生理盐水和未加载细胞的载体作为对照。在12周的随访期内进行椎间盘高度指数、T2加权磁共振成像(MRI)和组织学分析,以评估修复效果。影像学显示,与退变对照组相比,加载载体和细胞的治疗均改善了结果,加载细胞的载体始终优于仅用载体治疗的椎间盘。组织学评估支持了这些发现,显示两个治疗组均有细胞外基质恢复的趋势。虽然两种生物材料都显示出修复潜力,但HA在支持NP细胞促进椎间盘再生方面表现出更高的一致性。这些结果强调了HA作为基于NP细胞疗法的优质载体在解决椎间盘退变方面的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9592/11639827/29f39f170673/cells-13-01984-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9592/11639827/409771abfeed/cells-13-01984-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9592/11639827/e1e063c8b311/cells-13-01984-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9592/11639827/77b9db96ace3/cells-13-01984-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9592/11639827/29f39f170673/cells-13-01984-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9592/11639827/409771abfeed/cells-13-01984-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9592/11639827/e1e063c8b311/cells-13-01984-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9592/11639827/77b9db96ace3/cells-13-01984-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9592/11639827/29f39f170673/cells-13-01984-g004.jpg

相似文献

1
Alginate vs. Hyaluronic Acid as Carriers for Nucleus Pulposus Cells: A Study on Regenerative Outcomes in Disc Degeneration.藻酸盐与透明质酸作为髓核细胞载体的比较:椎间盘退变再生结果的研究
Cells. 2024 Nov 30;13(23):1984. doi: 10.3390/cells13231984.
2
Genipin cross-linked type II collagen/chondroitin sulfate composite hydrogel-like cell delivery system induces differentiation of adipose-derived stem cells and regenerates degenerated nucleus pulposus.金合欢素交联型 II 型胶原蛋白/硫酸软骨素复合水凝胶样细胞输送系统诱导脂肪来源干细胞分化并再生退变的髓核。
Acta Biomater. 2018 Apr 15;71:496-509. doi: 10.1016/j.actbio.2018.03.019. Epub 2018 Mar 16.
3
Regeneration of the intervertebral disc with nucleus pulposus cell-seeded collagen II/hyaluronan/chondroitin-6-sulfate tri-copolymer constructs in a rabbit disc degeneration model.应用核芯细胞-胶原 II/透明质酸/硫酸软骨素 6 位双糖共聚物构建体在兔椎间盘退变模型中对椎间盘的再生。
Spine (Phila Pa 1976). 2011 Dec 15;36(26):2252-9. doi: 10.1097/BRS.0b013e318209fd85.
4
Injectable smart-blended hydrogel cross-linked with Vanillin to accelerate differentiation of intervertebral disc-derived stem cells (IVDSCs) for promoting degenerative nucleolus pulposus in a rat model.可注射智能混合水凝胶与香草醛交联,以加速椎间盘源性干细胞 (IVDSCs) 的分化,用于促进大鼠模型中的退行性髓核。
Inflammopharmacology. 2024 Oct;32(5):3443-3459. doi: 10.1007/s10787-024-01554-4. Epub 2024 Aug 29.
5
Photo-crosslinked gelatin-hyaluronic acid methacrylate hydrogel-committed nucleus pulposus-like differentiation of adipose stromal cells for intervertebral disc repair.光交联明胶-透明质酸甲基丙烯酰胺水凝胶促进脂肪基质细胞向椎间盘样分化用于椎间盘修复。
J Tissue Eng Regen Med. 2019 Apr;13(4):682-693. doi: 10.1002/term.2841. Epub 2019 Mar 19.
6
Tissue-engineered allograft intervertebral disc transplantation for the treatment of degenerative disc disease: experimental study in a beagle model.组织工程同种异体椎间盘移植治疗退行性椎间盘疾病:比格犬模型的实验研究。
Tissue Eng Part A. 2013 Jan;19(1-2):143-51. doi: 10.1089/ten.TEA.2012.0255. Epub 2012 Nov 5.
7
Injectable decellularized nucleus pulposus-based cell delivery system for differentiation of adipose-derived stem cells and nucleus pulposus regeneration.注射型去细胞髓核细胞递送系统促进脂肪来源干细胞向髓核细胞分化和髓核组织再生。
Acta Biomater. 2018 Nov;81:115-128. doi: 10.1016/j.actbio.2018.09.044. Epub 2018 Sep 27.
8
A comparison between nucleus pulposus-derived stem cell transplantation and nucleus pulposus cell transplantation for the treatment of intervertebral disc degeneration in a rabbit model.兔模型中髓核来源干细胞移植与髓核细胞移植治疗椎间盘退变的比较
Int J Surg. 2016 Apr;28:77-82. doi: 10.1016/j.ijsu.2016.02.045. Epub 2016 Feb 17.
9
Injection of human umbilical tissue-derived cells into the nucleus pulposus alters the course of intervertebral disc degeneration in vivo.将人脐带组织来源的细胞注射到髓核中可改变体内椎间盘退变的过程。
Spine J. 2013 Mar;13(3):263-72. doi: 10.1016/j.spinee.2012.12.004. Epub 2013 Feb 4.
10
Effect of perfluorotributylamine-enriched alginate on nucleus pulposus cell: Implications for intervertebral disc regeneration.富氟三丁胺海藻酸盐对髓核细胞的影响:对椎间盘再生的启示。
Biomaterials. 2016 Mar;82:34-47. doi: 10.1016/j.biomaterials.2015.12.013. Epub 2015 Dec 19.

引用本文的文献

1
Innovative Approaches for the Treatment of Spinal Disorders: A Comprehensive Review.脊柱疾病治疗的创新方法:全面综述
J Orthop Sports Med. 2025;7(1):144-161. doi: 10.26502/josm.511500190. Epub 2025 Mar 27.

本文引用的文献

1
Identification of CD44 as a key engager to hyaluronic acid-rich extracellular matrices for cell traction force generation and tumor invasion in 3D.鉴定CD44是富含透明质酸的细胞外基质的关键结合分子,其在三维环境中产生细胞牵引力并促进肿瘤侵袭。
Matrix Biol. 2025 Feb;135:1-11. doi: 10.1016/j.matbio.2024.11.004. Epub 2024 Nov 9.
2
The proteomic landscape of extracellular vesicles derived from human intervertebral disc cells.源自人椎间盘细胞的细胞外囊泡的蛋白质组学概况。
JOR Spine. 2024 Nov 5;7(4):e70007. doi: 10.1002/jsp2.70007. eCollection 2024 Dec.
3
Allogenic bone marrow-derived mesenchymal stromal cell-based therapy for patients with chronic low back pain: a prospective, multicentre, randomised placebo controlled trial (RESPINE study).
同种异体骨髓来源间充质基质细胞治疗慢性下腰痛患者的前瞻性、多中心、随机安慰剂对照试验(RESPINE 研究)。
Ann Rheum Dis. 2024 Oct 21;83(11):1572-1583. doi: 10.1136/ard-2024-225771.
4
Assessment of Tie2-Rejuvenated Nucleus Pulposus Cell Transplants from Young and Old Patient Sources Demonstrates That Age Still Matters.评估来自年轻和老年患者来源的 Tie2 再生活体细胞移植,结果表明年龄仍然很重要。
Int J Mol Sci. 2024 Jul 30;25(15):8335. doi: 10.3390/ijms25158335.
5
Biomolecular therapies for chronic discogenic low back pain: A narrative review.慢性椎间盘源性下腰痛的生物分子疗法:一项叙述性综述。
JOR Spine. 2024 Aug 6;7(3):e1345. doi: 10.1002/jsp2.1345. eCollection 2024 Sep.
6
Cryopreserving the intact intervertebral disc without compromising viability.冷冻保存完整的椎间盘而不损害其活力。
JOR Spine. 2024 Aug 5;7(3):e1351. doi: 10.1002/jsp2.1351. eCollection 2024 Sep.
7
In silico modeling the potential clinical effect of growth factor treatment on the metabolism of human nucleus pulposus cells.在计算机模拟生长因子治疗对人髓核细胞代谢的潜在临床效果。
JOR Spine. 2024 Jul 31;7(3):e1352. doi: 10.1002/jsp2.1352. eCollection 2024 Sep.
8
Getting to the Core: Exploring the Embryonic Development from Notochord to Nucleus Pulposus.深入核心:探索从脊索到髓核的胚胎发育过程。
J Dev Biol. 2024 Jul 3;12(3):18. doi: 10.3390/jdb12030018.
9
Allogeneic Disc Progenitor Cells Safely Increase Disc Volume and Improve Pain, Disability, and Quality of Life in Patients With Lumbar Disc Degeneration-Results of an FDA-Approved Biologic Therapy Randomized Clinical Trial.同种异体椎间盘祖细胞可安全增加椎间盘体积,并改善腰椎间盘退变患者的疼痛、功能障碍和生活质量——一项美国食品药品监督管理局批准的生物疗法随机临床试验的结果。
Int J Spine Surg. 2024 Jul 4;18(3):237-248. doi: 10.14444/8609.
10
A comprehensive review of cell transplantation and platelet-rich plasma therapy for the treatment of disc degeneration-related back and neck pain: A systematic evidence-based analysis.细胞移植和富血小板血浆疗法治疗椎间盘退变相关颈肩腰腿痛的综合综述:基于证据的系统分析
JOR Spine. 2024 Jun 24;7(2):e1348. doi: 10.1002/jsp2.1348. eCollection 2024 Jun.